Katja Rosenkranz Ph.D Overview

  • Primary Position
  • Partner

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 3

  • Med. Deal Size

  • Med. Valuation

Katja Rosenkranz Ph.D General Information

Biography

Dr. Katja Rosenkranz serves as Board Member at Dualyx. She serves as Partner at V-Bio Ventures and Jay Therapeutics. She serves as Board Observer at ExeVir Bio. She also served as Board Member at AgomAb Therapeutics. Before joining V-Bio Ventures, she spent more than 12 years in the life science venture business. She worked as an analyst at Polytechnos Venture-Partners and as CBO/CFO at Hepa Wash. Subsequently, she was a senior investment and project manager at Ascenion, where she managed the Spinnovator initiative and progressed early academic inventions to create spin-offs. She holds a Ph.D. and MSc in Biochemistry from Witten/Herdecke University, Germany, and an Executive MBA in Medical Devices and Healthcare Management from the IBST, Tuttlingen, Germany. She spent more than 12 years in the life science venture business. She worked as an analyst at PolyTechnos Venture-Partners and as CBO/CFO at Hepa Wash. Subsequently, she was a senior investment and project manager at Ascenion, where she managed the Spinnovator initiative and progressed early academic inventions to create spin-offs. She holds a Ph.D. and MSc in Biochemistry from Witten/Herdecke University, Germany, and an Executive MBA in Medical Devices and Healthcare Management from the IBST, Tuttlingen, Germany.

Contact Information

Primary Position
Education
Witten/Herdecke University, Ph.D. (Doctor of Philosophy)
Witten/Herdecke University, MS (Master of Science)
Gender
Female
Email
ka
Address
  • Pieter Van Ryesshootlaan 2 box 104
  • Sint-Denijs-Westrem
  • 9051 Ghent
  • Belgium

Katja Rosenkranz Ph.D Positions (1)

Firm name Firm type Title Location Industry Since
V-Bio Ventures Investor Partner Ghent, Belgium Venture Capital

Katja Rosenkranz Ph.D Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Dualyx Drug Discovery Privately Held (backing) Venture Capital-Backed Ghent, Belgium
ExeVir Drug Discovery Privately Held (backing) Venture Capital-Backed Ghent, Belgium
Jay Therapeutics Other Healthcare Services Privately Held (backing) Venture Capital-Backed Gent, Belgium

Katja Rosenkranz Ph.D Lead Partner on Deals (4)

Katja Rosenkranz Ph.D has been the lead partner on 4 deals. Their latest deal was with Dualyx, a drug discovery company. The deal was made for on 15-May-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Dualyx 15-May-2023 Early Stage VC (Series A) Completed Drug Discovery Ghent, Belgium
AgomAb 13-Jul-2022 Completed Drug Discovery Antwerp, Belgium
ExeVir 16-Mar-2021 Early Stage VC (Series A) Completed Drug Discovery Ghent, Belgium
AgomAb 10-Oct-2019 Early Stage VC (Series A) Completed Drug Discovery Antwerp, Belgium

Katja Rosenkranz Ph.D Network (59)

Board Members (32)

Name Company Representing Location From
Ohad Hammer AgomAb Pontifax Venture Capital Antwerp, Belgium
Juliette Audet Dualyx Forbion Ghent, Belgium
ExeVir Self Ghent, Belgium
AgomAb Redmile Group Antwerp, Belgium
AgomAb Self Antwerp, Belgium

Portfolio Executives (23)

Name Company Role Deal date Location
Wouter Verhoeven Dualyx Chief Executive Officer 15-May-2023 Ghent, Belgium
Luc Van Rompaey Ph.D Dualyx Founder & Chief Scientific Officer 15-May-2023 Ghent, Belgium
AgomAb Co-Founder 13-Jul-2022 Antwerp, Belgium
AgomAb Board Member & Chairman of the Audit Committee 13-Jul-2022 Antwerp, Belgium
AgomAb Chief Financial Officer 13-Jul-2022 Antwerp, Belgium

Fund Team Members (4)

Name Investor Fund Fund Location
Christina Takke Ph.D V-Bio Ventures V-Bio Ventures Fund I Ghent, Belgium
Christina Takke Ph.D V-Bio Ventures V-Bio Ventures Fund II Ghent, Belgium
V-Bio Ventures Ghent, Belgium
V-Bio Ventures Ghent, Belgium
V-Bio Ventures Ghent, Belgium

Katja Rosenkranz Ph.D Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
V-Bio Ventures Fund I V-Bio Ventures Venture - General Closed 2016
V-Bio Ventures Fund II V-Bio Ventures Venture - General Closed 2022

Katja Rosenkranz Ph.D FAQs

  • Who is Katja Rosenkranz Ph.D?

    Dr. Katja Rosenkranz serves as Board Member at Dualyx.

  • How much does Katja Rosenkranz Ph.D typically invest?

    Katja Rosenkranz Ph.D's median deal size is .

  • What is Katja Rosenkranz Ph.D’s main position?

    Katja Rosenkranz Ph.D’s primary position is Partner.

  • How many active board seats does Katja Rosenkranz Ph.D hold?

    Katja Rosenkranz Ph.D holds 3 board seats including Dualyx, ExeVir, and Jay Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »